Printer Friendly

PathAlert Infectious-Agent Detection System.

PathAlert[TM] Detection System, a cost-effective screening and confirmatory detection system for infectious agents, has undergone successful evaluations coordinated by the U.S. Department of Defense and the U.S. Environmental Protection Agency (U.S. EPA). In those tests, the system was shown to be sensitive and specific for the identification of air and waterborne pathogens.

The PathAlert Detection System can be used by government, military, and research organizations for accurate detection of infectious agents such as Bacillus anthracis (anthrax), Yersinia pestis (plague), Vaccinia (smallpox simulant), and Francisella tularensis (tularemia) in samples collected from the air, food, and water. According to the U.S. EPA assessment, the system accurately detected infectious agents such as anthrax and plague in drinking water with no false positives or false negatives at expected sensitivity levels.

Each PathAlert Detection Kit is a reagent system optimized for the detection of a specific infectious agent. Based on multiplex-PCR, the kits detect multiple regions of pathogen DNA and include internal and external controls, greatly reducing false-positive and false-negative readings. Using the PathAlert multiplex-PCR kits with the Agilent 2100 bioanalyzer and DNA chip and reagent kits, users can monitor DNA targets and controls simultaneously without the constraints imposed by conventional real-time PCR. Agilent's 5100 Automated Labon-a-Chip Platform can be used for biodefense applications requiring high-throughput analysis. The PathAlert System also provides less costly capabilities for detecting anthrax, plague, smallpox simulant, and tularemia.

The system also offers the unique capability of multi-agent analysis in a single assay based on the biothreat agents of interest in a specific matrix, such as water, food, or animal feed. It is being co-marketed by Invitrogen Corporation and Agilent Technologies, Inc.

For more information on the PathAlert System, contact Greg Geissman by phone at (760) 476-7032 or by e-mail at gregory.geissman@invitrogen.com, or visit www.invitrogen.com.
COPYRIGHT 2005 National Environmental Health Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Products & Services
Publication:Journal of Environmental Health
Date:Oct 1, 2005
Words:304
Previous Article:Early detection of disease outbreaks.
Next Article:New SafetyTech National Guard WMD Response kit.


Related Articles
Physician assertiveness will prevent outbreaks of illness. (Security Beat).
Electron microscopy for rapid diagnosis of infectious agents in emergent situations (1). (Synopses).
Detecting bioterror attacks by screening blood donors: a best-case analysis. (Perspectives).
Evaluating detection and diagnostic decision support systems for bioterrorism response.
Emerging issues for the public health laboratory (2).
Detecting biological warfare agents.
Early detection of disease outbreaks.
Protecting public health in the age of bioterrorism surveillance: is the price right?
Emerging infectious determinants of chronic diseases.
Detection of infectious poxvirus particles.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |